Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000827809-19-000007
Filing Date
2019-04-26
Accepted
2019-04-26 09:00:38
Documents
3
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A nvln-12312018x10ka.htm 10-K/A 489297
2 EXHIBIT 31.1 nvln-12312018xex311.htm EX-31.1 6155
3 EXHIBIT 31.2 nvln-12312018xex312.htm EX-31.2 5863
  Complete submission text file 0000827809-19-000007.txt   502698
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Filer) CIK: 0000827809 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-17082 | Film No.: 19769540
SIC: 2834 Pharmaceutical Preparations